IODVA1, a guanidinobenzimidazole derivative, targets Rac activity and Ras-driven cancer models.
Gasilina A, Premnauth G, Gurjar P, Biesiada J, Hegde S, Milewski D, Ma G, Kalin TV, Merino E, Meller J, Seibel W, Cancelas JA, Vinnedge LP, Nassar NN.
Gasilina A, et al. Among authors: nassar nn.
PLoS One. 2020 Mar 12;15(3):e0229801. doi: 10.1371/journal.pone.0229801. eCollection 2020.
PLoS One. 2020.
PMID: 32163428
Free PMC article.